Method for modifying a treatment regimen of a human female subject
US10920279B2 · kind B2 · utility
0Cited by
13References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 29, 2015 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Oct 20, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods and systems for assessing the risk of a human female subject for developing breast cancer. In particular, the present disclosure relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.